Product image of Inovelon (Rufinamide) supplied by GNH India

Inovelon

Active Ingredient:
Rufinamide
Origin:
EU

Inovelon (Rufinamide)

Rufinamide, the active ingredient in Inovelon, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of Lennox‑Gastaut syndrome and other refractory epilepsies in patients who require adjunctive seizure control in children and adults.

GNH India supplies Inovelon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers. Our network spans multiple continents, facilitating timely delivery and support for therapeutic programs.

Manufacturer / TM Owner

Eisai Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Rufinamide is used as an adjunctive therapy in the management of severe epilepsy syndromes, particularly those resistant to standard treatments.
  • Lennox‑Gastaut syndrome: reduces the frequency of multiple seizure types in patients with this refractory epilepsy.
  • Other refractory epilepsies: provides additional seizure control when conventional antiepileptic drugs are insufficient.

How It Works

  • Rufinamide modulates voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing neuronal excitability. By prolonging the inactivated state of the channels, it reduces the likelihood of rapid firing of neurons that underlies seizure activity, thereby contributing to seizure control in refractory epilepsy syndromes.

Side Effects

Rufinamide may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

  • Dizziness: transient sensation of lightheadedness.
  • Fatigue: persistent tiredness affecting daily activities.
  • Nausea: mild to moderate upset stomach.
  • Somnolence: increased sleepiness during the day.
  • Headache: mild to moderate head pain.
  • Decreased appetite: reduced desire for food.

Serious or Rare Side Effects

  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Suicidal thoughts: emergence of depressive symptoms or ideation.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Blood dyscrasias: abnormal blood counts.
  • Cardiac arrhythmias: irregular heart rhythms.
  • Anaphylactic reaction: acute allergic response requiring emergency care.

Precautions & Warnings

  • When prescribing Rufinamide, clinicians should consider several safety aspects to minimize risk.
  • Renal impairment: adjust dose and monitor renal function.
  • Hepatic impairment: monitor liver enzymes and consider dose modification.
  • Concomitant enzyme inducers: be aware that drugs like carbamazepine may lower rufinamide levels.
  • Pregnancy: potential risk is unknown; avoid unless clearly needed.
  • Monitor for mood changes: watch for signs of depression or suicidal ideation.
  • Store at ambient temperature: keep in original packaging, protect from moisture and excessive heat.

Avoid Interactions

Rufinamide can interact with other medications, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Carbamazepine: reduces rufinamide plasma concentrations.
  • Phenobarbital: decreases rufinamide exposure.
  • Phenytoin: lowers rufinamide levels.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: may reduce hormonal efficacy.
  • CYP3A4 inhibitors: can increase rufinamide concentrations.
  • CNS depressants: additive sedation may occur.

Frequently Asked Questions

Inovelon contains the active ingredient rufinamide and is used as an adjunctive therapy for patients with Lennox‑Gastaut syndrome and other refractory epilepsies. It helps reduce the frequency of multiple seizure types when standard antiepileptic drugs are insufficient.

Rufinamide modulates voltage‑gated sodium channels, prolonging their inactivated state. This stabilizes neuronal membranes, decreases neuronal excitability, and reduces the likelihood of rapid firing that leads to seizures, thereby providing seizure control in severe epilepsy syndromes.

The dosage of Inovelon is individualized. A qualified prescriber determines the appropriate dose based on the patient’s age, weight, renal and hepatic function, and response to therapy. No fixed regimen is provided without medical supervision.

The safety of rufinamide in pregnancy and lactation has not been established. It is classified as unknown for pregnancy, and caution is advised. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider.

To order Inovelon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Inovelon (rufinamide) is distinguished by its specific modulation of sodium channels, which may be beneficial for patients with refractory seizure types. Compared with other antiepileptics, it offers a different mechanism and may be used when conventional therapies have failed, though individual response varies.

Inovelon should be stored at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and excessive heat, and ensure the packaging remains sealed until use.

Inovelon is taken orally, usually as tablets. It should be swallowed with water, and the dosing schedule is set by the prescribing physician. Patients should follow the prescribed timing and not alter the dose without medical advice.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, blood dyscrasias, cardiac arrhythmias, and the emergence of suicidal thoughts or depressive symptoms. Immediate medical attention is required if any of these occur.

Inovelon is contraindicated in patients with known hypersensitivity to rufinamide or any of its excipients. It should also be avoided in individuals with severe hepatic impairment or those taking interacting enzyme‑inducing antiepileptic drugs without appropriate dose adjustments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Rufinamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT